INBX · Company research
Inhibrx Biosciences, Inc. (INBX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (INBX) Volatility Zones as Tactical Triggers - Stock Traders Daily | (INBX) Volatility Zones as Tactical Triggers Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 16, 2026 | neutral | 0 | 0.6 |
| Inhibrx Biosciences, Inc. (INBX) stock price, news, quote and history - Yahoo Finance UK | Inhibrx Biosciences, Inc. (INBX) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| Two CEO-linked trusts buy 10,040 Inhibrx Biosciences (INBX) shares; no trading plan is reported. - Stock Titan | Two CEO-linked trusts buy 10,040 Inhibrx Biosciences (INBX) shares; no trading plan is reported. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Cancer-study presentations from Inhibrx will take place in Madrid, Miami and Seoul. - Stock Titan | Cancer-study presentations from Inhibrx will take place in Madrid, Miami and Seoul. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Inhibrx Stock Price Forecast. Should You Buy INBX? - StockInvest.us | Inhibrx Stock Price Forecast. Should You Buy INBX? StockInvest.us | View source ↗ | StockInvest.us | Oct 9, 2026 | neutral | 0 | 0.6 |
| INBX Stock Hit Record Highs: Retail Turns ‘Extremely Bullish’ On This Cancer Play - Stocktwits | INBX Stock Hit Record Highs: Retail Turns ‘Extremely Bullish’ On This Cancer Play Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup - MarketBeat | Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup MarketBeat | View source ↗ | MarketBeat | Oct 2, 2026 | neutral | 0 | 0.6 |
| Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? - Simply Wall Street | Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? Simply Wall Street | View source ↗ | Simply Wall Street | Sep 29, 2026 | neutral | 0 | 0.6 |
| Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. - Stock Titan | Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| $INBX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $INBX stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| $INBX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $INBX stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| Inhibrx (INBX) corrects director's 10,000-option grant - Stock Titan | Inhibrx (INBX) corrects director's 10,000-option grant Stock Titan | View source ↗ | Stock Titan | Sep 18, 2026 | neutral | 0 | 0.6 |
| Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act (NASDAQ:INBX) - Seeking Alpha | Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act (NASDAQ:INBX) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 17, 2026 | neutral | 0 | 0.6 |
| Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million - PR Newswire | Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million PR Newswire | View source ↗ | PR Newswire | Jul 16, 2026 | neutral | 0 | 0.6 |
| Inhibrx Reports First Quarter 2026 Financial Results - PR Newswire | Inhibrx Reports First Quarter 2026 Financial Results PR Newswire | View source ↗ | PR Newswire | May 14, 2026 | neutral | 0 | 0.6 |
| Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study - Yahoo Finance | Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study Yahoo Finance | View source ↗ | Yahoo Finance | May 14, 2026 | neutral | 0 | 0.6 |
| Inhibrx Biosciences, Inc. Common Stock (INBX) Stock Price: Oct 8 Close $92.76 - Gotrade | Inhibrx Biosciences, Inc. Common Stock (INBX) Stock Price: Oct 8 Close $92.76 Gotrade | View source ↗ | Gotrade | May 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.